Key clinical point: First prospective study shows better cancer-specific survival with surgical staging.
Major finding: 33% in the surgical staging group were up-staged, compared with 6% in the CT group.
Study details: A follow-up study of a randomized, controlled trial evaluating surgical staging over clinical staging in stage IIB-IVA cervical cancer in 235 women.
Disclosures: Dr. Tsunoda has received honoraria from AstraZeneca and Roche. Dr. Ramondetta has no relevant financial disclosures.
Tsunoda A et al. AAGL Global Congress.